Senior Director, Biostatistics Bicycle Therapeutics PlcSenior Director, BiostatisticsLexington, MA$235,000–$295,000 / yearThe company is evaluating nuzafatide pevedotin (formerly BT5528), a Bicycle Drug Conjugate (BDC) targeting EphA2, a historically undruggable target; a pipeline of Bicycle Radioconjugates (BRCs) and imaging agents; zelenectide pevedotin (formerly BT8009), a BDC targeting Nectin-4, a well-validated tumor antigen; and, through various partnerships, the use of Bicycle technology to develop therapies to treat diseases in a range of therapeutic areas. At Bicycle, we benefit from a hybrid style working arrangement, allowing our employees where possible the opportunity to collaborate and engage with their coworkers in person while also benefiting from the flexibility of home remote working.
Executive Director Biostatistics Lantheus Holdings IncExecutive Director BiostatisticsBedford, MA$206,000–$381,000 / yearThe Executive Director will serve as the project-level biostatistician, providing expertise in the development and execution of statistical strategies, study designs, statistical analyses, and regulatory submissions for clinical development across various therapeutic areas. He/she will collaborate closely with clinical science, regulatory, and other cross-functional teams to develop clinical development plans, author key clinical, regulatory, and statistical documents, and ensure the high-quality delivery and interpretation of clinical data.
Executive Director Biostatistics Lantheus Holdings, Inc.Executive Director BiostatisticsBedford, MA$206,000–$381,000 / yearThe Executive Director will serve as the project-level biostatistician, providing expertise in the development and execution of statistical strategies, study designs, statistical analyses, and regulatory submissions for clinical development across various therapeutic areas. He/she will collaborate closely with clinical science, regulatory, and other cross-functional teams to develop clinical development plans, author key clinical, regulatory, and statistical documents, and ensure the high-quality delivery and interpretation of clinical data.
Associate Director, Biostatistics Rhythm PharmaceuticalsAssociate Director, BiostatisticsBoston, MA$160,000–$240,000 / yearReporting to the Vice President, Head of Biostatistics & Statistical Programming, this individual will serve as a hands-on statistical lead for assigned studies or program activities, partnering across clinical, regulatory, safety, data management, and programming teams to support robust study design, high-quality analyses, and clear interpretation of results. Responsibilities and Duties Serve as the statistical lead for assigned clinical studies or defined program activities, contributing to clinical development plans, study design, sample size and power calculations, protocols, statistical analysis plans (SAPs), TLFs, data analyses, and interpretation of results.
Director, Biostatistics Summit Therapeutics IncDirector, BiostatisticsCambridge, MA$203,000–$253,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Experience, Education and Specialized Knowledge and Skills: PhD and a minimum of 8+ years of experience or Masters (MS) and a minimum of 11+ years of experience in statistics or biostatistics or related disciplines with clinical trials, pharmaceutical/biotech industry, or healthcare experience.
Director, Biostatistics Project Lead SanofiDirector, Biostatistics Project LeadWaltham, MA$178,500–$257,833.33 / yearBut progress doesn't happen without people - people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks' gender-neutral parental leave.
Senior Director, Biostatistics Beeline MedicinesSenior Director, BiostatisticsBoston, Massachusetts$242,000–$313,000 / yearLed by an established executive team and backed by world-class life science investors, each day Beeline Medicines is determined to bring the scientific rigor and operational excellence to get to what matters for patients – realizing a world where people with immune-mediated diseases can live life fully. Provide senior statistical leadership for assigned clinical programs — owning statistical strategy, trial design, and methodology across all phases of development (Phase I–III) and ensuring statistical approaches are scientifically rigorous, regulatorily defensible, and aligned with program objectives.
Senior Director, Biostatistics Rhythm PharmaceuticalsSenior Director, BiostatisticsBoston, MA$210,000–$300,000 / yearResponsibilities and Duties Serve as the lead statistician for assigned clinical programs, providing biostatistical strategy and leadership across clinical development plans, study design, sample size and power calculations, protocols, statistical analysis plans (SAPs), TLFs, data analyses, and interpretation of results. Reporting to the Vice President, Head of Biostatistics & Statistical Programming, this individual will partner across clinical, regulatory, safety, data management, programming, and medical writing/publications teams to provide strategic guidance, scientific judgment, and hands-on biostatistical expertise.
Director, Biostatistics TempusDirector, BiostatisticsBoston, MA$180,000–$240,000 / yearWe are seeking a highly motivated and capable Director of Biostatistics to lead a team of biostatisticians involved in multiple aspects of clinical research at Tempus. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Associate Director, Biostatistics Summit Therapeutics IncAssociate Director, BiostatisticsCambridge, MA$190,000–$210,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Review the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports.
Director, Biostatistics Les Laboratoires Servier SASDirector, BiostatisticsBoston, MARemote$204,000–$246,000 / yearAct as the biostatistics expert and leader, serve as primary statistical representative for cross-functional teams, including clinical, evidence generation, and asset teams, and communicate plans and strategy to subordinates. This role will lead the statistical strategy for assigned clinical development products or evidence generation across our portfolio and may supervise statisticians both in-house and at CROs, ensuring timely and high-quality biostatistics deliverables.
Associate Director, Biostatistics Rhythm Pharmaceuticals IncAssociate Director, BiostatisticsBoston, MA$160,000–$240,000 / yearReporting to the Vice President, Head of Biostatistics & Statistical Programming, this individual will serve as a hands-on statistical lead for assigned studies or program activities, partnering across clinical, regulatory, safety, data management, and programming teams to support robust study design, high-quality analyses, and clear interpretation of results. Serve as the statistical lead for assigned clinical studies or defined program activities, contributing to clinical development plans, study design, sample size and power calculations, protocols, statistical analysis plans (SAPs), TLFs, data analyses, and interpretation of results.
Director, Biostatistics Monte Rosa Therapeutics IncDirector, BiostatisticsBoston, MAThe Director will work closely with Clinical Development and external partners to drive trial design, analysis strategies, and regulatory-ready outputs while remaining directly involved in study-level statistical activities. The Director of Biostatistics is a hands-on statistical leader responsible for the design, analysis, and interpretation of Phase 1-Phase 3 clinical trials with a primary focus on inflammation and oncology indications.
Senior Manager/Associate Director, Biostatistics Beam Therapeutics IncSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Director, Biostatistics Treeline Biosciences, Inc.Director, BiostatisticsWatertown, MA$226,425–$257,000 / yearSAPs & Output: Author trial-specific Statistical Analysis Plans, design shell tables, listings, and figures (TLFs), and write statistical sections of Clinical Study Reports (CSRs). Unsolicited resumes sent to Treeline Biosciences from recruiters do not constitute any type of relationship between the recruiter and Treeline Biosciences and do not obligate Treeline Biosciences in any way to pay fees should we hire from those resumes.
Director, Biostatistics Treeline Biosciences IncDirector, BiostatisticsWatertown, MA$226,425–$257,000 / yearSAPs & Output: Author trial-specific Statistical Analysis Plans, design shell tables, listings, and figures (TLFs), and write statistical sections of Clinical Study Reports (CSRs). Unsolicited resumes sent to Treeline Biosciences from recruiters do not constitute any type of relationship between the recruiter and Treeline Biosciences and do not obligate Treeline Biosciences in any way to pay fees should we hire from those resumes.
Sr. Director, Biostatistics Atavistik Bio IncSr. Director, BiostatisticsCambridge, MA$270,000–$290,000 / yearAtavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management. Oversee and lead the vendor/CRO biostatistics and programming teams, including activities during TFL development, Data Monitoring Safety Board meetings, interim analyses, and database locks.
Associate Director, Biostatistics PepGen Inc.Associate Director, BiostatisticsBoston, MA$205,000–$236,000 / yearProvide input to help optimize trial designs for pivotal registrational studies; maintain strong competencies in statistical methodology and trial designs, particularly in therapeutic areas such as neuromuscular diseases or other rare diseases, with familiarity with ICH, FDA, and EMA guidelines. The Associate Director will serve as a statistical subject-matter expert on our cross-functional team, contributing to protocol development, study design, statistical analysis, regulatory submissions, publications and presentations, as well as supporting the management of CRO and external vendors.
Associate Director, Biostatistics ReplimuneAssociate Director, BiostatisticsWoburn, Massachusetts$193,500–$250,500 / yearThe RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. For this role, the anticipated base pay range is $193,500-$250,500The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience.
Director, Biostatistics Bicara Therapeutics IncDirector, BiostatisticsBoston, MAFICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF--driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF- ligand trap.